Inducible Pericyte-Specific Cre Mouse Model for Adult Brain Study

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current models of pericyte deficiency, such as those with disrupted PDGF-BB and PDGFRβ signaling, are not specific to pericytes and cannot isolate the contribution of other PDGFRβ-expressing CNS cell types, making it difficult to understand the role of pericytes in adult brain function and disease.

Innovation Solution

A double-promoter strategy using the Pdgfrβ and Cspg4 promoters to generate a pericyte-specific Cre line, allowing for inducible ablation of pericytes using the diphtheria toxin receptor, which enables specific targeting and study of pericyte function in the adult brain.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If PDGF-BB and PDGFRβ signaling is disrupted in pericyte-deficient mouse models, then insights into pericyte biology and neurovascular function regulation are obtained, but specificity to pericytes is lost because other PDGFRβ-expressing CNS cell types cannot be isolated

Engineering Contradiction:
Improvespecificity of pericyte targetingVSAvoidcomplexity of genetic model
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The genetic model is segmented into multiple independent components: Pdgfrb promoter driving Flippase expression, Cspg4 promoter driving Frt-Stop-Frt-CreER expression, and the ultimate Cre-mediated DTR expression. This segmentation allows each promoter to contribute to pericyte-specificity while the modular design manages the overall complexity of the system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Two independent transgenic lines (Pdgfrb-Flp and Cspg4-FSF-CreER) are merged through breeding to create the pericyte-specific Cre model. This combination leverages the complementary specificity of both promoters, with Pdgfrb providing pericyte enrichment and Cspg4 providing additional pericyte-specific expression, achieving high specificity while distributing genetic complexity across multiple loci.

Inventive Principle:
Principle #5Merging (Combining)

2Reliability

If embryonic PDGFRβ signaling is disrupted, then pericyte development can be studied, but developmental impacts on neurovascular and neuronal phenotype cannot be distinguished from adult pericyte function

Engineering Contradiction:
Improveability to isolate adult pericyte functionVSAvoidtime required to achieve adult phenotype
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The CreER-T2 system is preliminarily installed in pericytes during development through the Cspg4 promoter, but the actual Cre-mediated recombination is delayed until adult stages by controlling CreER activation timing. This preliminary setup ensures pericyte identity is established while allowing temporal separation of developmental processes from adult function studies.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The model transitions from a static embryonic knockout approach to a dynamic, temporally controllable system. CreER-T2 activity can be induced at different time points using tamoxifen administration, allowing researchers to study pericyte function at specific developmental stages or in adult animals, thereby separating developmental effects from adult physiological roles.

Inventive Principle:
Principle #15Dynamics

3Measurement precision

If pericytes are ablated using traditional models, then neurovascular dysfunction and BBB breakdown are observed, but the contribution of pericyte degeneration to neurodegeneration cannot be clearly established

Engineering Contradiction:
Improveprecision in attributing neurodegeneration to pericyte lossVSAvoidcomplexity of ablation model
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The diphtheria toxin receptor (DTR) is extracted and specifically expressed only in pericytes through the pericyte-specific Cre system. When diphtheria toxin is administered, it selectively targets and kills pericytes expressing DTR, while leaving other cell types intact. This extraction of pericyte-specific killing capability allows precise attribution of observed neurodegenerative changes to pericyte loss alone.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The DTR system acts as an intermediary between the researcher and pericyte ablation. Instead of directly targeting pericytes with complex genetic deletions, the DTR provides a controllable, toxin-mediated ablation mechanism that is activated only in pericytes. This intermediary system simplifies the ablation process while maintaining high specificity, enabling clear causal inference between pericyte loss and neurodegenerative outcomes.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the precise ablation of pericytes, demonstrating rapid dysregulation of cerebral blood flow, blood-brain barrier breakdown, and behavioral deficits, highlighting the contribution of pericyte degeneration to neurodegeneration and suggesting new therapeutic strategies.

Implementation Method 1

allowing for inducible ablation of pericytes using the diphtheria toxin receptor, which enables specific targeting and study of pericyte function in the adult brain

Methodology Applied
Scientific EffectDiphtheria toxin mechanism:

Data Source

PatentUS10342221B2Generation of an inducible pericyte-specific CRE mouse model
Publication Date: 2019.07.09 UNIV OF SOUTHERN CALIFORNIA
  • US10342221B2 patent drawing
  • US10342221B2 patent drawing
  • US10342221B2 patent drawing

AI summary

Pericytes are mural cells of brain capillaries that degenerate in multiple neurological disorders. Pericytes regulate neurovascular functions, but their role in the adult brain and disease is still poorly understood because of the lack of adequate pericyte-specific experimental models. All current pericyte-deficient models are not pericyte specific, and carry an inherited embryonic trait. Here, the Inventors generated an inducible pericyte-specific Cre line using a double-promoter strategy. The Inventors ablated adult mouse pericytes expressing Cre-dependent diphtheria toxin receptor after toxin administration. Pericyte ablation led to a rapid dysregulation of cerebral blood flow and blood-brain barrier breakdown. This was followed by behavioral deficits and neurodegenerative changes. These findings show that circulatory deficits leading to secondary neurodegeneration develop immediately after pericyte loss.